Production (Stage)
Evolutionary Genomics, Inc.
FNAM
$0.0002
-$0.0006-75.00%
OTC PK
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 0.00 | -654.40K | -27.80K | 2.20K | -100.00 |
| Gross Profit | 0.00 | 654.40K | 27.80K | -2.20K | 100.00 |
| SG&A Expenses | 1.60M | 1.69M | 1.66M | 1.65M | 1.64M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.01M | 2.27M | 2.87M | 2.89M | 2.88M |
| Operating Income | -2.01M | -2.27M | -2.87M | -2.89M | -2.88M |
| Income Before Tax | -1.94M | -2.27M | -2.78M | -2.81M | -2.79M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.94 | -2.27 | -2.78 | -2.81 | -2.79 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.94M | -2.27M | -2.78M | -2.81M | -2.79M |
| EBIT | -2.01M | -2.27M | -2.87M | -2.89M | -2.88M |
| EBITDA | -992.90K | -1.24M | -1.84M | -1.85M | -1.84M |
| EPS Basic | -0.35 | -0.41 | -0.51 | -0.53 | -0.52 |
| Normalized Basic EPS | -0.19 | -0.23 | -0.30 | -0.31 | -0.31 |
| EPS Diluted | -0.35 | -0.41 | -0.51 | -0.53 | -0.53 |
| Normalized Diluted EPS | -0.19 | -0.23 | -0.30 | -0.31 | -0.31 |
| Average Basic Shares Outstanding | 25.83M | 25.06M | 24.29M | 23.54M | 23.53M |
| Average Diluted Shares Outstanding | 25.83M | 25.06M | 24.29M | 23.54M | 23.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |